Barchart on MSN7h
Analyst: Sell ‘Magnificent 7’ Stocks and Buy These 3 Dividend Stocks Instead
The stock market saw something incredible in 2024, with the “Magnificent 7” tech giants leading the charge and driving a huge ...
Exelixis: Bullish On Cabo, Not So Convinced By It's Long-Term Replacement, Zanza
Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate ...
14 Places Where Homes Are Now Taking Forever to Sell (Most Are in Florida or Texas)
Read 14 Places Where Homes Are Now Taking Forever to Sell (Most Are in Florida or Texas) from Money Talks News. The timing of coffee consumption may influence your risk of premature death from ...
Novo, Eli Lilly to dominate global pharma sales in 2025: report
Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...
This Unpopular Dividend Stock Is a Buy
This double-digit growth in new drug sales showcases the company's ability to successfully commercialize cutting-edge ...
First Hawaiian Bank Grows Stock Position in Bristol-Myers Squibb (NYSE:BMY)
First Hawaiian Bank raised its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.5% during the 4th quarter, ...
International Assets Investment Management LLC Decreases Stake in Bristol-Myers Squibb (NYSE:BMY)
International Assets Investment Management LLC cut its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 98.4% ...